STOCK TITAN

BlackRock (XRAY) holds 12.6% of DENTSPLY SIRONA common stock

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

BlackRock, Inc. reported beneficial ownership of 25,295,015 shares of DENTSPLY SIRONA INC common stock, representing 12.6% of the class as of 06/30/2026. The filing shows sole voting power over 24,804,969 shares and sole dispositive power over 25,295,015 shares.

Positive

  • None.

Negative

  • None.

Insights

BlackRock holds a double-digit stake in DENTSPLY SIRONA.

The Schedule 13G/A lists 25,295,015 shares beneficially owned, equal to 12.6% of the outstanding common stock as of 06/30/2026. The filing attributes sole voting power for 24,804,969 shares and sole dispositive power for the full holding.

Large passive holders can affect shareholder voting outcomes when aggregated; subsequent filings or amendments could change position size or voting classification. Future disclosures will show any material changes.

Filing is a passive ownership disclosure under Schedule 13G/A.

Language on the cover notes holdings reflect certain Reporting Business Units of BlackRock and excludes other BlackRock units. The statement in Item 6 notes various persons may have rights to dividends or sale proceeds but none exceed 5% individually.

Investors and the company should track any reclassification to Schedule 13D or further amendments, which would indicate active intent or coordinated action.

Beneficial ownership 25,295,015 shares as of 06/30/2026
Percent of class 12.6% percentage of outstanding common stock
Sole voting power 24,804,969 shares voting power reported on filing
Sole dispositive power 25,295,015 shares dispositive power reported on filing
Schedule 13G/A regulatory
"Amendment No. 15 ) DENTSPLY SIRONA INC Common Stock"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
beneficially owned financial
"Amount beneficially owned: 25295015"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole dispositive power regulatory
"Sole power to dispose or to direct the disposition of: 25295015"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does BlackRock report in DENTSPLY SIRONA (XRAY)?

BlackRock reports beneficial ownership of 25,295,015 shares, representing 12.6% of DENTSPLY SIRONA common stock as of 06/30/2026. The filing is a Schedule 13G/A disclosure of passive holdings by reporting business units.

How much voting power does BlackRock report for XRAY shares?

BlackRock reports sole voting power over 24,804,969 shares of DENTSPLY SIRONA common stock as disclosed on the filing dated 06/30/2026. Shared voting power is reported as 0 shares.

Does the Schedule 13G/A show BlackRock will sell or buy XRAY shares?

The filing reports current beneficial ownership and voting/dispositive power; it does not state any planned purchases or sales. Transaction intent or changes would appear in later amendments or different filings.

Who signed the BlackRock 13G/A for DENTSPLY SIRONA and when?

The Schedule 13G/A was signed by Spencer Fleming, Managing Director, with the signature dated 07/08/2026 and the reported ownership amount tied to 06/30/2026.





24906P109

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



BlackRock, Inc.
Signature:Spencer Fleming
Name/Title:Managing Director
Date:07/08/2026
Exhibit Information

Exhibit 24: Power of Attorney Exhibit 99: Item 7